Endo International plc – Ordinary Shares (ENDP) was Reiterated by Barclays to “Equal Weight” while Lowering the Price Target of the company shares to $ 28 from a previous price target of $37 . Barclays advised their investors in a research report released on May 6, 2016.
Many Wall Street Analysts have commented on Endo International plc – Ordinary Shares. Shares were Reiterated by Stifel on May 6, 2016 to “Buy” and Lowered the Price Target to $ 75 from a previous price target of $90 .Endo International plc – Ordinary Shares was Downgraded by Piper Jaffray to ” Neutral” on May 6, 2016. Endo International plc – Ordinary Shares was Downgraded by Leerink Partners to ” Mkt Perform” on May 6, 2016.
On the company’s financial health, Endo International plc – Ordinary Shares reported $1.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on May 5, 2016. Analyst had a consensus of $1.04. The company had revenue of $963.54 million for the quarter, compared to analysts expectations of $956.08 million. The company’s revenue was up 34.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.17 EPS.
In a different news, on Apr 21, 2016, William P Montague (director) sold 3,413 shares at $42.19 per share price. According to the SEC, on Mar 17, 2016, William Spengler (director) purchased 1,000 shares at $29.20 per share price. On Mar 14, 2016, Roger H Kimmel (director) purchased 1,125 shares at $41.94 per share price, according to the Form-4 filing with the securities and exchange commission.